Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 7/20 | 0.64 |
| ▸ | HPGD | P15428 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | TYR | P14679 | 1/20 | 0.57 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8925892 | 1.00 | ALDH1A1 (0.69) | ALDH1A1POLBMAPTHPGDLMNA | |
| SCHEMBL29655344 | 1.00 | ALDH1A1 (0.69) | ALDH1A1POLBMAPTHPGDLMNA | |
| SCHEMBL891274 | 1.00 | ALDH1A1 (0.69) | ALDH1A1POLBMAPTHPGDLMNA | |
| SCHEMBL19019462 | 0.93 | MAPT (0.64) | ALDH1A1POLBMAPTHPGDLMNA | |
| SCHEMBL7193653 | 0.93 | MAPT (0.64) | ALDH1A1POLBMAPTHPGDLMNA | |
| SCHEMBL14627791 | 0.91 | ALDH1A1 (0.57) | ALDH1A1POLBMAPTHPGDLMNA | |
| SCHEMBL13268894 | 0.91 | ALDH1A1 (0.57) | ALDH1A1POLBMAPTHPGDLMNA | |
| SCHEMBL13268895 | 0.91 | ALDH1A1 (0.57) | ALDH1A1POLBMAPTHPGDLMNA | |
| SCHEMBL22926905 | 0.87 | ALDH1A1 (0.69) | ALDH1A1POLBMAPTHPGDLMNA | |
| SCHEMBL10604093 | 0.87 | ALDH1A1 (0.69) | ALDH1A1POLBMAPTHPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113038842-B | Aerosol formulation | 尼科创业贸易有限公司 | 2023-11-03 | — | — | CN | claimed |
| CN-113056208-B | Aerosol formulation | 尼科创业贸易有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-113260261-A | Nebulizable formulations | 尼科创业贸易有限公司 | 2021-08-13 | — | — | CN | claimed |
| CN-109776281-B | Synthesis method of ethyl isoeugenol | 南京林业大学 | 2020-10-13 | — | — | CN | claimed |
| EP-2621462-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | The Procter and Gamble Company (US) | 2013-08-07 | — | — | EP | claimed |
| CN-103140209-A | Oral care compositions with improved flavor | PROCTER & GAMBLE | 2013-06-05 | — | — | CN | claimed |
| WO-2012044728-A1 | ORAL CARE COMPOSITIONS WITH IMPROVED FLAVOR | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-05 | — | — | WO | claimed |
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | THE PROCTER & GAMBLE COMPANY | 2012-04-05 | — | — | US | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| US-20070166341-A1 | Solid volatile composition and method and system for making the same | INTERNATIONAL ARTS & SCIENCE GROUP, INC. | 2007-07-19 | — | — | US | claimed |
| JP-9249549-A | — | — | None | — | — | JP | disclosed |
| JP-9124409-A | — | — | None | — | — | JP | disclosed |
| JP-6287135-A | — | — | None | — | — | JP | disclosed |
| JP-9241116-A | — | — | None | — | — | JP | disclosed |
| US-20250302014-A1 | WASP PEST MANAGEMENT SYSTEM | TONER DARADH (IE) | 2025-10-02 | — | — | US | disclosed |
| JP-H09241116-A | COSMETIC COMPOSITION | LION CORP | 1997-09-16 | — | — | JP | disclosed |
| JP-H09124409-A | ATTRACTANT FOR CUPREOUS CHAFER | JAPAN TOBACCO INC | 1997-05-13 | — | — | JP | disclosed |
| JP-H06287135-A | EXTERNAL AGENT COMPOSITION FOR SKIN | LION CORP | 1994-10-11 | — | — | JP | disclosed |
| US-4154769-A | Process for the production of 2-alkoxy-4-propen-1-yl-phenols | HAARMANN & REIMER GMBH (DE) | 1979-05-15 | — | — | US | disclosed |
| US-4071564-A | Process for the production of 2-alkoxy-4-alkenyl phenols | HAARMANN & REIMER GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | TRPA1, TAS2R40, TAS2R30 | ALDH1A1 1558/4885POLB 1808/4885MAPT 4044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.